TYP 9.76% 4.5¢ tryptamine therapeutics limited

Ann: Ceasing to be a substantial holder, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 435 Posts.
    lightbulb Created with Sketch. 224
    and if it all collapses he's no worse off financially than he was last week and he gets substantial access to the IP (whatever Dixon doesn't get first). That assumes it's the play he is looking at. Who knows? Maybe he just wants out and was prepared to recoup at least something?
    Anyway, ASX/ASIC still have to approve it all though. Lots of water to flow under the bridge yet.
    All I know is this has turned out to be a complete basket case after being promoted as a the next big thing in biotech.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
0.004(9.76%)
Mkt cap ! $49.00M
Open High Low Value Volume
4.1¢ 4.8¢ 4.0¢ $416.7K 9.464M

Buyers (Bids)

No. Vol. Price($)
3 308891 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 22225 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.